NBC Securities’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45.8K Buy
15,711
+1,338
+9% +$4.66K ﹤0.01% 1337
2026
Q2
$50.2K Buy
14,373
+5,333
+59% +$17.2K ﹤0.01% 1291
2026
Q1
$26K Buy
9,040
+6,940
+330% +$27.3K ﹤0.01% 1598
2025
Q4
$8.55K Buy
+2,100
New +$9.4K ﹤0.01% 2068

Other funds holding SANA

NBC Securities's SANA Position: Q3 2026 in Review

NBC Securities increased its Sana Biotechnology (SANA) stake by 9.3% in Q3 2026, buying an estimated $4.66K and bringing the position to 15,711 shares worth $45.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

NBC Securities first reported a position in SANA in Q4 2025 and has held it in 4 quarters since. The position peaked at $50.2K in Q2 2026. 34 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • NBC Securities held 15,711 shares of Sana Biotechnology worth $45.8K as of Q3 2026.
  • NBC Securities bought 1,338 Sana Biotechnology shares in Q3 2026, an estimated $4.66K.
  • Sana Biotechnology made up ﹤0.01% of NBC Securities's portfolio in Q3 2026, its #1337 holding.
  • NBC Securities first reported a position in Sana Biotechnology in Q4 2025 and has held it in 4 quarters since.
  • NBC Securities's Sana Biotechnology position peaked at $50.2K in Q2 2026.
  • 34 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.